Synthetic Biology Market 2019 Product & Application Development Analysis

1
Synthetic Biology Market
Publication Month May 2018 Report Code
TIPHE100000960 No. of Pages 150 Category
Biotechnology Status Published
Synthetic Biology Market to 2025 - Global
Analysis and Forecasts by Products (Enzymes,
Chassis Organisms, Oligonucleotides, Xeno-Nucleic
Acids) By Technology (Measurement Modeling,
Cloning Sequencing, Gene Synthesis,
Nanotechnology) and Application (Medical
Applications, Industrial Applications, Food and
Agriculture, Environmental Applications)
E-Mail  sales_at_theinsightpartners.com
2
Synthetic Biology Market
Publication Month May 2018 Report Code
TIPHE100000960 No. of Pages 150 Category
Biotechnology Status Published
Introduction Synthetic biology, an
interdisciplinary branch of biology and
engineering, involves designing and constructing
new devices, systems and biological parts as well
as re-designing existing, natural biological
systems. It has various application in the field
of food agriculture, medicine, and other areas.
Technologies such as, gene synthesis, genome
engineering and cloning and sequencing help the
researchers to understand organization of natural
biological systems and design new biological
entities offering various advantages to
humans. The synthetic biology market is
estimated to grow at a CAGR of 28.2 during the
forecast period from 2018 to 2025. The market for
synthetic biology is estimated to reach US
56,044.9 Mn in 2025.
E-Mail  sales_at_theinsightpartners.com
3
Synthetic Biology Market
Publication Month May 2018 Report Code
TIPHE100000960 No. of Pages 150 Category
Biotechnology Status Published
In our study, we have segmented the synthetic
biology market by product, technology and
application. On the basis of product, the market
is segmented into enzymes, oligonucleotides,
chassis organisms and xeno-nucleic acids. Enzymes
acquired the largest market among the products
due to its wide range of applications in
healthcare. On the basis of technology, the
market is segmented into gene synthesis, genome
engineering, measurement and modeling, cloning
and sequencing, nanotechnology, and others. Gene
synthesis has the largest market share among the
technologies due to an increasing research and
development activities in genetics and growing
number of market players offering products and
solutions for gene synthesis. On the basis of
application, global synthetic biology market is
segmented into industrial applications, food and
agriculture, medical applications, environmental
applications, and others. Geographically, the
market for synthetic biology is segmented into
North America, Europe, Asia Pacific (APC), Middle
East and Africa (MEA) and South and Central
America (SCAM).The market for synthetic
biology is witnessing a potential growth rate
during the previous years and is expected to
witness similar trend in the coming years. Global
synthetic biology market is driven by extensive
use of enzymes kits and other gene synthesis
products in research institutes and academics.
Additionally, rising demand for enzyme based kits
and solutions required for gene manipulation and
rising awareness about genetic engineering among
the healthcare professionals in developed nations
also accelerate the market growth. However,
competition among existing market players may
restrain the growth of the market.
E-Mail  sales_at_theinsightpartners.com
4
Synthetic Biology Market
Publication Month May 2018 Report Code
TIPHE100000960 No. of Pages 150 Category
Biotechnology Status Published
In North America, the market is driven by an
increasing investment by government organizations
and institutes such as Department of Energy, the
National Science Foundation (NSF), Department Of
Defense (DoD), the National Institutes of Health
(NIH), and the US Department of Agriculture
(USDA). While, Asia Pacific is the fastest
growing market driven increasing investment by
private sector companies such as Evolva Biotech
Pvt. Ltd and increasing demand for synthetic
biology technologies of industrial and medical
applications. The global synthetic biology
market is a matured market in the developing
countries as well as developing economies
worldwide. Increasing number of start-up
companies is a major driver for the growth of
synthetic biology market. In the recent years,
there has been a significant rise in the number
of start-up companies in the US. Various
government initiatives and funding programs for
biotechnology enable the entrepreneurs of these
start-ups to raise funds, equipment and space in
respective regions. For instance Indie Bio, a
synthetic biology accelerator program headquarter
at California, US and Ireland offers funding and
mentorship through its three-month training
program. Moreover, the technological advancement
has headed emergence of the New Bioeconomy, which
is the replacement of petrochemical-based
manufacturing and fermentation-based
manufacturing products. In addition, the
investments from public and private investors are
rising for the synthetic biology. The rise in the
investment are enabling technological
developments and standard biological parts.
E-Mail  sales_at_theinsightpartners.com
5
Synthetic Biology Market
Publication Month May 2018 Report Code
TIPHE100000960 No. of Pages 150 Category
Biotechnology Status Published

• Companies Profiled are
• 1. Thermo Fisher Scientific Inc.2. Merck KGaA3.
  Novozymes4. Agilent Technologies5. Amyris6.
  GenScript 7. Integrated DNA Technologies,
  Inc.8. Twist Bioscience9. New England Biolabs
  10. Synthetic Genomics Inc.

Get Sample PDF
E-Mail  sales_at_theinsightpartners.com